3 Stocks Pushing The Consumer Non-Durables Industry Higher

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 52 points (0.3%) at 17,129 as of Tuesday, Aug. 26, 2014, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,998 issues advancing vs. 975 declining with 164 unchanged.

The Consumer Non-Durables industry currently sits up 0.4% versus the S&P 500, which is up 0.2%. A company within the industry that increased today was Michael Kors Holdings ( KORS), up 0.8%.

TheStreet would like to highlight 3 stocks pushing the industry higher today:

3. Ecolab ( ECL) is one of the companies pushing the Consumer Non-Durables industry higher today. As of noon trading, Ecolab is up $0.77 (0.7%) to $115.35 on light volume. Thus far, 270,729 shares of Ecolab exchanged hands as compared to its average daily volume of 793,500 shares. The stock has ranged in price between $114.47-$115.46 after having opened the day at $114.93 as compared to the previous trading day's close of $114.58.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Ecolab Inc. provides water, hygiene, and energy technologies and services for customers worldwide. The company operates in four segments: Global Industrial, Global Institutional, Global Energy, and Other. Ecolab has a market cap of $34.1 billion and is part of the consumer goods sector. Shares are up 9.9% year-to-date as of the close of trading on Monday. Currently there are 11 analysts who rate Ecolab a buy, no analysts rate it a sell, and 3 rate it a hold.

TheStreet Ratings rates Ecolab as a buy. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income, revenue growth, good cash flow from operations and expanding profit margins. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full Ecolab Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2. As of noon trading, Lululemon Athletica ( LULU) is up $1.00 (2.5%) to $41.83 on average volume. Thus far, 1.3 million shares of Lululemon Athletica exchanged hands as compared to its average daily volume of 3.4 million shares. The stock has ranged in price between $40.77-$42.14 after having opened the day at $40.87 as compared to the previous trading day's close of $40.83.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

lululemon athletica inc., together with its subsidiaries, designs, manufactures, and distributes athletic apparel and accessories for women, men, and female youth. It operates in three segments: Corporate-Owned Stores, Direct To Consumer, and Other. Lululemon Athletica has a market cap of $4.7 billion and is part of the consumer goods sector. Shares are down 30.8% year-to-date as of the close of trading on Monday. Currently there are 8 analysts who rate Lululemon Athletica a buy, 1 analyst rates it a sell, and 16 rate it a hold.

TheStreet Ratings rates Lululemon Athletica as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and a generally disappointing performance in the stock itself. Get the full Lululemon Athletica Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1. As of noon trading, International Paper ( IP) is up $0.50 (1.1%) to $47.71 on light volume. Thus far, 1.2 million shares of International Paper exchanged hands as compared to its average daily volume of 3.7 million shares. The stock has ranged in price between $47.22-$47.76 after having opened the day at $47.30 as compared to the previous trading day's close of $47.21.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

International Paper Company operates as a paper and packaging company in North America, Europe, Latin America, Russia, Asia, and the Middle East. International Paper has a market cap of $20.1 billion and is part of the consumer goods sector. Shares are down 3.7% year-to-date as of the close of trading on Monday. Currently there are 7 analysts who rate International Paper a buy, 1 analyst rates it a sell, and 4 rate it a hold.

TheStreet Ratings rates International Paper as a buy. The company's strongest point has been its expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full International Paper Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the consumer non-durables industry could consider Consumer Staples Select Sector SPDR ( XLP) while those bearish on the consumer non-durables industry could consider ProShares Ultra Sht Consumer Goods ( SZK).

null

More from Markets

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing